Physician
Anson Pediatrics INC
Anson Pediatrics INC was paid $4.33M by Medicaid between Jan 2018 and Oct 2024, across 71 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 22% of everything it billed.
33Billing provider infoANSON PEDIATRICS INC
WADESBORO, NC 28170
WADESBORO, NC 28170
33aNPI1225166804assigned 03/02/2007
33bProvider typePediatrics Physician
28Total paid$4.33M
24GClaims270,443
24DCodes billed71
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Pediatrics Physician providers in North Carolina
Rank by total paid#91 of 433
Median peer was paid$942K
This provider vs. median4.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 34,841 | $763K | |
| 2019 | 27,708 | $736K | |
| 2020 | 16,386 | $460K | |
| 2021 | 39,083 | $621K | |
| 2022 | 62,131 | $752K | |
| 2023 | 58,905 | $667K | |
| 2024incomplete | 31,389 | $327K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 16,450 | 13,289 | $932K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 9,121 | 7,704 | $764K |
| 99199 | Unlisted special service, procedure or report | 17% | 129,143 | 78,538 | $737K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.5% | 2,770 | 2,345 | $238K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.3% | 2,634 | 2,248 | $229K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.3% | 2,110 | 1,698 | $185K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 3.9% | 1,575 | 1,369 | $168K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.8% | 1,867 | 1,657 | $164K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3.6% | 8,856 | 7,622 | $158K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 3.2% | 4,470 | 3,884 | $140K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.1% | 5,659 | 4,831 | $135K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 1.6% | 329 | 65 | $70K |
59 more codes
| 92567 | 1.3% | 6,783 | $57K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.3% | 4,524 | $56K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 10,719 | $55K |
| D0145 | Oral evaluation for a patient under three years of age | 1.1% | 1,598 | $49K |
| 96127 | <1% | 10,065 | $33K | |
| 88738 | <1% | 4,442 | $24K | |
| D1206 | Topical application of fluoride varnish | <1% | 1,611 | $22K |
| 80061 | Lipid panel | <1% | 1,508 | $18K |
| 87807 | <1% | 1,282 | $16K | |
| 90474 | <1% | 616 | $12K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,188 | $10K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 65 | $10K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 3,512 | $5K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 692 | $5K |
| 90651 | <1% | 838 | $4K | |
| 81002 | <1% | 7,607 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 262 | $4K |
| 95117 | <1% | 382 | $3K | |
| 96161 | <1% | 833 | $3K | |
| 99381 | <1% | 31 | $2K | |
| 96111 | <1% | 22 | $2K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 109 | $2K |
| 92551 | <1% | 7,087 | $2K | |
| 90734 | <1% | 521 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 701 | $1K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 19 | $1K |
| 99173 | <1% | 7,415 | $1K | |
| 83655 | <1% | 239 | $743.20 | |
| 90686 | <1% | 2,764 | $740.64 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 37 | $535.85 |
| 90697 | <1% | 377 | $416.16 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 104 | $260.85 |
| 90670 | <1% | 1,693 | $224.49 | |
| 90620 | <1% | 108 | $206.56 | |
| 90715 | <1% | 183 | $185.46 | |
| 90619 | <1% | 154 | $160.06 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 210 | $153.93 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 14 | $132.34 |
| 81025 | <1% | 16 | $78.91 | |
| 36416 | <1% | 650 | $37.92 | |
| 90633 | <1% | 675 | $34.10 | |
| 94760 | <1% | 133 | $6.41 | |
| 90710 | 0% | 614 | $0.00 | |
| 83525 | 0% | 169 | $0.00 | |
| 90658 | 0% | 345 | $0.00 | |
| 84439 | 0% | 170 | $0.00 | |
| 90671 | 0% | 128 | $0.00 | |
| 90685 | 0% | 108 | $0.00 | |
| 84481 | 0% | 169 | $0.00 | |
| 90707 | 0% | 19 | $0.00 | |
| 90700 | 0% | 53 | $0.00 | |
| 90698 | 0% | 409 | $0.00 | |
| 90647 | 0% | 195 | $0.00 | |
| 90680 | 0% | 692 | $0.00 | |
| 90696 | 0% | 88 | $0.00 | |
| 90744 | 0% | 152 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 170 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 171 | $0.00 |
| 90723 | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialELLIOTT, SARAH (CEO)
| Provider | Location | Paid |
|---|---|---|
| Avery Mae Pediatrics LLC | Thompsons Station, TN | $249K |
| Lacy Coker Kessler, MD, PA | Waco, TX | $5K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.